-
2015
Company Description
Inositec AG is a biotech spin-off from ETH Zurich
Inositec AG is a biotech spin-off from ETH Zurich. The Company develop innovative new drugs using its proprietary technology Inositune to adjust the properties of inositol phosphate analogs. Initially, Inositec will focus on two areas of high-unmet medical need: calcification disorders and Clostridium difficile infection (CDI).
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Founders:
Mattias Ivarsson -
Company Website:
-
Company E-mail:
-
Company Address:
Technoparkstrasse 1 Otto-Stern-Weg 7ZürichSwitzerland -
CEO:
- Mattias Ivarsson
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits